Sutro Biopharma, Inc. (STRO)
9.33
-0.96
(-9.33%)
USD |
NASDAQ |
Oct 23, 16:00
9.335
0.00 (0.00%)
After-Hours: 20:00
Sutro Biopharma Market Cap : 154.66M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 154.66M |
| October 22, 2026 | 170.57M |
| October 21, 2026 | 178.86M |
| October 20, 2026 | 191.29M |
| October 19, 2026 | 186.57M |
| October 16, 2026 | 181.34M |
| October 15, 2026 | 189.96M |
| October 14, 2026 | 174.38M |
| October 13, 2026 | 182.50M |
| October 12, 2026 | 220.13M |
| October 09, 2026 | 236.54M |
| October 08, 2026 | 253.95M |
| October 07, 2026 | 243.01M |
| October 06, 2026 | 239.53M |
| October 05, 2026 | 250.80M |
| October 02, 2026 | 254.44M |
| October 01, 2026 | 264.72M |
| September 30, 2026 | 267.04M |
| September 29, 2026 | 266.88M |
| September 28, 2026 | 265.72M |
| September 25, 2026 | 264.89M |
| September 24, 2026 | 260.41M |
| September 23, 2026 | 260.74M |
| September 22, 2026 | 267.37M |
| September 21, 2026 | 271.02M |
| Date | Value |
|---|---|
| September 18, 2026 | 254.28M |
| September 17, 2026 | 256.60M |
| September 16, 2026 | 258.59M |
| September 15, 2026 | 274.50M |
| September 14, 2026 | 280.30M |
| September 11, 2026 | 279.47M |
| September 10, 2026 | 295.55M |
| September 09, 2026 | 304.26M |
| September 08, 2026 | 316.61M |
| September 04, 2026 | 332.68M |
| September 03, 2026 | 340.48M |
| September 02, 2026 | 339.31M |
| September 01, 2026 | 345.12M |
| August 31, 2026 | 335.50M |
| August 28, 2026 | 338.98M |
| August 27, 2026 | 353.24M |
| August 26, 2026 | 355.23M |
| August 25, 2026 | 355.39M |
| August 24, 2026 | 339.65M |
| August 21, 2026 | 348.76M |
| August 20, 2026 | 350.75M |
| August 19, 2026 | 363.18M |
| August 18, 2026 | 365.34M |
| August 17, 2026 | 369.32M |
| August 14, 2026 | 339.48M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Upstream Bio, Inc. | 150.07M |
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
Market Cap Related Metrics
| PS Ratio | 2.385 |
| PEG Ratio | -0.0108 |
| Price | 9.33 |
| Earnings Yield | -186.6% |
| PEGY Ratio | -0.0108 |